文献速递神经技术与安全PET

在三种蛋白病相关神经退行性小鼠模型中应用[18F]ROStrace进行活性氧的新型无创PET显像

Novel Non-Invasive PET Imaging of Reactive Oxygen Species Using [18 F]ROStrace in Three Proteinopathy-Associated Neurodegenerative Mouse Models.
PubMed 文献 · Acad Radiol · 2025-08-14

研究在APP/PS1(阿尔茨海默病)、A53T(帕金森病)和PS19(4R tau蛋白病)三种蛋白病相关神经退行性小鼠模型中评估超氧阴离子敏感性PET示踪剂[18F]ROStrace。各组小鼠在不同年龄接受[18F]ROStrace注射后行60分钟动态micro-PET扫描,24小时后取脑组织免疫荧光分析。结果显示[18F]ROStrace能高灵敏度检测三种模型氧化应激增高,且示踪剂滞留的区域性升高与错误折叠蛋白异常聚集及氧化损伤强相关;作者认为其有潜力改善神经退行性疾病的诊断、病情监测和疗效评估。

要点

  • [18F]ROStrace在三种蛋白病相关神经退行性小鼠模型中均高灵敏度检测到氧化应激增高。
  • 示踪剂滞留的区域性升高与错误折叠蛋白异常聚集及氧化损伤强相关。
  • 该示踪剂有潜力用于神经退行性疾病的早期识别、病情监测和疗效评估。

核心结论

  • 作者认为[18F]ROStrace通过实现氧化应激的早期识别,在改善神经退行性疾病诊断、监测疾病轨迹和评估针对氧化损伤的治疗干预方面具有显著潜力。

研究设计与样本

  • 研究使用三种蛋白病相关神经退行性小鼠模型:APP/PS1(阿尔茨海默病)、A53T(帕金森病)和PS19(4R tau蛋白病)。每组小鼠在不同年龄接受[18F]ROStrace注射,随后行60分钟动态micro-PET扫描;24小时后收集脑组织行免疫荧光,以将示踪剂滞留与蛋白病诱导的氧化损伤进行关联。

关键影像表现/征象

  • [18F]ROStrace在三种神经退行性动物模型中均高灵敏度检测到氧化应激增高。
  • 示踪剂滞留的区域性升高与错误折叠蛋白异常聚集及氧化损伤强相关,可定位不同神经退行性条件下受累脑区。

诊断标准与关键数值

  • [18F]ROStrace为超氧阴离子(O₂·⁻)敏感性PET示踪剂,用于检测活性氧。
  • 示踪剂滞留与蛋白病诱导的氧化损伤通过注射后24小时脑组织免疫荧光进行关联分析。

临床应用与阅片要点

  • 原文结论认为[18F]ROStrace有潜力改善神经退行性疾病的诊断、监测疾病轨迹和评估针对氧化损伤的治疗干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Prolonged oxidative stress, driven by aggregation of misfolded proteins such as amyloid beta (Aβ), alpha-synuclein (aSyn), and tau, plays a key role in neurodegenerative disease (ND) progression. Yet, the lack of noninvasive tools to monitor oxidative stress in vivo limits clinical tracking of disease. To address this, we evaluated [18 F]ROStrace, a novel superoxide (O₂·⁻)-sensitive PET tracer, in three proteinopathy-associated ND mouse models.

MATERIALS AND METHODS: To validate [18 F]ROStrace's reactive oxygen species (ROS)-detecting ability across different types of NDs, we used three proteinopathy-associated ND mouse models: APP/PS1 (Alzheimer's disease, [AD]), A53T (Parkinson's disease, [PD]), and PS19 (4R tauopathy, [AD]). Each group of mice received [18 F]ROStrace injections at various ages, followed by 60 min dynamic micro-PET scans. Brain tissues were collected 24 h later for immunofluorescence to correlate tracer retention with proteinopathy-induced oxidative damage.

RESULTS: [18 F]ROStrace is highly sensitive in detecting increased oxidative stress in all three ND animal models. Furthermore, region-specific elevations in [18 F]ROStrace retention strongly correlated with the abnormal aggregation of misfolded proteins and oxidative damage, highlighting the tracer's ability to pinpoint affected brain areas in different neurodegenerative conditions.

CONCLUSIONS: By enabling early identification of oxidative stress, [18 F]ROStrace holds significant potential for improving ND diagnosis, monitoring disease trajectory, and evaluating therapeutic interventions targeting oxidative damage.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu Y, McManus MJ, Mach RH, et al. Novel Non-Invasive PET Imaging of Reactive Oxygen Species Using [18 F]ROStrace in Three Proteinopathy-Associated Neurodegenerative Mouse Models. Acad Radiol. 2025. PMID: 40816922. doi:10.1016/j.acra.2025.07.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。